Background International guidelines do not provide uniform recommendations regarding the
use of antiplatelet treatment in the perioperative period in patients undergoing coronary …

Objective Antiplatelet therapy after coronary artery bypass grafting (CABG) is important in
postoperative medical management. Although cardiac surgeons are well-versed in the …

We read with great interest the article authored by Miceli et al.[1] regarding the most correct
timing for dual antiplatelet therapy withdrawal before surgical myocardial revascularization …

OBJECTIVES The purpose of this multicentre cohort study was to examine the relationship
between antiplatelet therapy (APT) at the time of coronary artery bypass grafting (CABG) and …

The management of coronary patients scheduled for a coronary artery bypass grafting
(CABG), who are receiving one or more antiplatelet drugs, is plenty of controversies. It has …

Objectives The aim of the present study was to define the feasibility and clinical impact of
complying with national consensus recommendations on perioperative management of …

Background Dual antiplatelet therapy is the cornerstone treatment for patients with acute
coronary syndrome. Recent Canadian Guidelines recommend the use of dual antiplatelet …

Addressing the optimal management approach for patients who are receiving single or dual
antiplatelet therapy is a common and sometimes challenging clinical problem, especially for …

Background We assessed the effectiveness of dual antiplatelet therapy (DAPT) post elective
or urgent (ie, post acute coronary syndrome [ACS]) coronary artery bypass graft surgery …

Background: Antiplatelet therapy is critical in the management of coronary artery disease.
For patients undergoing coronary artery bypass graft surgery (CABG), controversy remains …